IncytevsMerck & Company

INCY and MRK stock compared: price, dividend, valuation and results, from SEC filings.

INCY

Incyte Corporation

$117.80

Value $23.4B

-1.08%
INCY's page

MRK

Merck & Company, Inc.

$137.78

Value $341B

-3.90%
MRK's page

Incyte (INCY) has a market value of $23.4B and Merck & Company (MRK) $341B. Over the last year, with dividends, INCY moved +13.1% and MRK +52.7%. The P/E is 58.1 for INCY and 138.9 for MRK. Dividend yield: INCY none, MRK 2.47%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    INCY$23.4B

    MRK$341B

    MRK is 15 times INCY

  • Revenue, 12 months

    INCY$6.0B

    MRK$67.4B

    MRK is 11 times INCY

  • Net income, 12 months

    INCY$403M

    MRK$2.5B

    MRK is 6.1 times INCY

  • Operating margin

    INCY10.4%

    MRK–

  • ROIC

    INCY9.0%

    MRK3.9%

    5.1 points apart

  • P/E

    INCY58.1

    MRK138.9

    MRK is 2.4 times INCY

  • Dividend yield

    INCY0.0%

    MRK2.5%

    2.5 points apart

  • 5-year return

    INCY+81.2%

    MRK+94.3%

    13.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

INCY+81.2%

MRK+94.3%

10015020020222023202420252026
Returns by period
PeriodINCYWith dividendsMRKWith dividends
1 year since November 17, 2025+13.1%Price +13.1%+52.7%Price +48.4%
3 years since November 17, 2023+117.1%+29.5% a yearPrice +117.1%+48.4%+14.1% a yearPrice +35.4%
5 years since November 17, 2021+81.2%+12.6% a yearPrice +81.2%+94.3%+14.2% a yearPrice +66.8%
10 years since November 21, 2016+9.0%+0.9% a yearPrice +9.0%+214.5%+12.1% a yearPrice +131.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

INCYIncyteMRKMerck & Company

Valuation

INCYMRK
Valuation
Price$117.80$137.78
Market value$23.4B$341B
Enterprise value (EV)$19.6B$385B
P/E58.1138.9
P/E, 5-year median20.414.8
P/B4.27.6
EV/EBIT31.380.8
Free cash flow yield2.9%4.3%

Results and growth

INCYMRK
Results and growth
Revenue, 12 months$6.0B$67.4B
Net income, 12 months$403M$2.5B
Free cash flow, 12 months$685M$14.7B
Earnings per share, 12 months$1.88$0.98
Revenue growth, year on year21.2%1.3%
Revenue growth a year, past+14.0%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

INCYMRK
Margins and returns on capital
Gross margin92.7%71.8%
Operating margin10.4%–
Net margin6.7%3.6%
ROIC9.0%3.9%
ROE7.4%5.2%

Balance sheet

INCYMRK
Balance sheet
Cash$3.9B$9.7B
Total debt$37M$53.8B
Net debt / EBITDA-5.35.7
Interest cover268.0×2.4×

Dividends and buybacks

INCYMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.5%
Shareholder yield–4.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: INCY or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Incyte or Merck & Company?

By market value, Merck & Company ($341B) is about 14.5 times Incyte ($23.4B), at today's prices.

How did INCY and MRK stock do over the last 10 years?

Since November 21, 2016, INCY's price moved +9.0% and MRK's +131.8%. With dividends: INCY +9.0% (+0.9% a year), MRK +214.5% (+12.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, INCY or MRK?

The dividend yield at today's price is none for Incyte and 2.47% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of INCY and MRK?

At today's price, the P/E is 58.1 for INCY and 138.9 for MRK. The median of the last five years was 20.4 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Incyte or Merck & Company?

Over the last twelve months, the net margin was 6.7% for Incyte and 3.6% for Merck & Company, and the operating margin 10.4% and –. Revenue was $6.0B and $67.4B.

Which is the better investment, Incyte or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.